293 related articles for article (PubMed ID: 37280220)
1. Drug screening at single-organoid resolution via bioprinting and interferometry.
Tebon PJ; Wang B; Markowitz AL; Davarifar A; Tsai BL; Krawczuk P; Gonzalez AE; Sartini S; Murray GF; Nguyen HTL; Tavanaie N; Nguyen TL; Boutros PC; Teitell MA; Soragni A
Nat Commun; 2023 Jun; 14(1):3168. PubMed ID: 37280220
[TBL] [Abstract][Full Text] [Related]
2. 3D bioprinting for organ and organoid models and disease modeling.
Juraski AC; Sharma S; Sparanese S; da Silva VA; Wong J; Laksman Z; Flannigan R; Rohani L; Willerth SM
Expert Opin Drug Discov; 2023; 18(9):1043-1059. PubMed ID: 37431937
[TBL] [Abstract][Full Text] [Related]
3. Immersion bioprinting of hyaluronan and collagen bioink-supported 3D patient-derived brain tumor organoids.
Clark CC; Yoo KM; Sivakumar H; Strumpf K; Laxton AW; Tatter SB; Strowd RE; Skardal A
Biomed Mater; 2022 Dec; 18(1):. PubMed ID: 36332268
[TBL] [Abstract][Full Text] [Related]
4. Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications.
Maharjan S; Ma C; Singh B; Kang H; Orive G; Yao J; Shrike Zhang Y
Adv Drug Deliv Rev; 2024 May; 208():115237. PubMed ID: 38447931
[TBL] [Abstract][Full Text] [Related]
5. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation.
Dai R; Chen W; Chen Y; Jin J; Zhang S; Zhang C; Liu J
Biofabrication; 2024 Jun; 16(3):. PubMed ID: 38810618
[TBL] [Abstract][Full Text] [Related]
6. High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and Heterogeneity.
Huang D; Leslie KA; Guest D; Yeshcheulova O; Roy IJ; Piva M; Moriceau G; Zangle TA; Lo RS; Teitell MA; Reed J
Anal Chem; 2018 Mar; 90(5):3299-3306. PubMed ID: 29381859
[TBL] [Abstract][Full Text] [Related]
7. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation.
Lawlor KT; Vanslambrouck JM; Higgins JW; Chambon A; Bishard K; Arndt D; Er PX; Wilson SB; Howden SE; Tan KS; Li F; Hale LJ; Shepherd B; Pentoney S; Presnell SC; Chen AE; Little MH
Nat Mater; 2021 Feb; 20(2):260-271. PubMed ID: 33230326
[TBL] [Abstract][Full Text] [Related]
8. 3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.
Mollica PA; Booth-Creech EN; Reid JA; Zamponi M; Sullivan SM; Palmer XL; Sachs PC; Bruno RD
Acta Biomater; 2019 Sep; 95():201-213. PubMed ID: 31233891
[TBL] [Abstract][Full Text] [Related]
9. Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
Hou S; Tiriac H; Sridharan BP; Scampavia L; Madoux F; Seldin J; Souza GR; Watson D; Tuveson D; Spicer TP
SLAS Discov; 2018 Jul; 23(6):574-584. PubMed ID: 29673279
[TBL] [Abstract][Full Text] [Related]
10. Acoustic Bioprinting of Patient-Derived Organoids for Predicting Cancer Therapy Responses.
Chen H; Wu Z; Gong Z; Xia Y; Li J; Du L; Zhang Y; Gao X; Fan Z; Hu H; Qian Q; Ding Z; Guo S
Adv Healthc Mater; 2022 Jul; 11(13):e2102784. PubMed ID: 35358375
[TBL] [Abstract][Full Text] [Related]
11. Volumetric Bioprinting of Organoids and Optically Tuned Hydrogels to Build Liver-Like Metabolic Biofactories.
Bernal PN; Bouwmeester M; Madrid-Wolff J; Falandt M; Florczak S; Rodriguez NG; Li Y; Größbacher G; Samsom RA; van Wolferen M; van der Laan LJW; Delrot P; Loterie D; Malda J; Moser C; Spee B; Levato R
Adv Mater; 2022 Apr; 34(15):e2110054. PubMed ID: 35166410
[TBL] [Abstract][Full Text] [Related]
12. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
13. Consistent and reproducible cultures of large-scale 3D mammary epithelial structures using an accessible bioprinting platform.
Reid JA; Mollica PA; Bruno RD; Sachs PC
Breast Cancer Res; 2018 Oct; 20(1):122. PubMed ID: 30305139
[TBL] [Abstract][Full Text] [Related]
14. Message in a Scaffold: Natural Biomaterials for Three-Dimensional (3D) Bioprinting of Human Brain Organoids.
Layrolle P; Payoux P; Chavanas S
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671410
[TBL] [Abstract][Full Text] [Related]
15. Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low-Concentration Collagen-Based Bioinks.
Shi W; Mirza S; Kuss M; Liu B; Hartin A; Wan S; Kong Y; Mohapatra B; Krishnan M; Band H; Band V; Duan B
Adv Healthc Mater; 2023 Oct; 12(26):e2300905. PubMed ID: 37422447
[TBL] [Abstract][Full Text] [Related]
16. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
[TBL] [Abstract][Full Text] [Related]
17. Developments and Opportunities for 3D Bioprinted Organoids.
Ren Y; Yang X; Ma Z; Sun X; Zhang Y; Li W; Yang H; Qiang L; Yang Z; Liu Y; Deng C; Zhou L; Wang T; Lin J; Li T; Wu T; Wang J
Int J Bioprint; 2021; 7(3):364. PubMed ID: 34286150
[TBL] [Abstract][Full Text] [Related]
18. Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research - State-of-the-art.
Frankowski J; Kurzątkowska M; Sobczak M; Piotrowska U
Int J Pharm; 2023 Sep; 644():123313. PubMed ID: 37579828
[TBL] [Abstract][Full Text] [Related]
19. Challenges in Bio-fabrication of Organoid Cultures.
Peng W; Datta P; Wu Y; Dey M; Ayan B; Dababneh A; Ozbolat IT
Adv Exp Med Biol; 2018; 1107():53-71. PubMed ID: 29855825
[TBL] [Abstract][Full Text] [Related]
20. Assay establishment and validation of a high-throughput organoid-based drug screening platform.
Li X; Fu G; Zhang L; Guan R; Tang P; Zhang J; Rao X; Chen S; Xu X; Zhou Y; Deng Y; Lv T; He X; Mo S; Mu P; Gao J; Hua G
Stem Cell Res Ther; 2022 May; 13(1):219. PubMed ID: 35619149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
